Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry
2011; 199: 441–2.
Lambert, T, Newcomer, J.
Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Med J Australia
2009; 190 (suppl 4): 39–42.
Royal College of Psychiatrists. Physical Health in Mental Health (Occasional Paper OP67). Royal College of Psychiatrists, 2009.
Ray, A, Chung, C, Murray, K, Hall, K, Stein, C.
Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med
2009; 360: 225–35.
Kessing, LV, Thomsen, AF, Mogensen, UB, Andersen, PK. Treatment with antipsychotics and the risk of diabetes in clinical practice. Br J Psychiatry
2010; 197: 266–71.
Joukamaa, M, Heliövaara, H, Knekt, P, Aromaa, A, Raitasalo, R, Lehtinen, V.
Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry
2006; 188: 122–7.
Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness. Br J Psychiatry
1996; 169: 733–9.
Brown, S, Barraclough, B, Inskip, H.
Causes of the excess mortality of schizophrenia. Br J Psychiatry
2000; 177: 212–7.
Lawrence, DM, Holman, CD'AJ, Jablensky, AV, Hobbs, MST. Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998. Br J Psychiatry
2003; 182: 31–6.
Marder, S, Essock, S, Miller, A, Buchanan, R, Casey, D, David, J, et. al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry
2004; 161: 1334–49.
Hennekens, C, Hennekens, A, Hollar, D, Casey, D.
Schizophrenia and increased risks of cardiovascular disease. Am Heart J
2005; 150: 1115–21.
Gubbins, A, Lally, J, McDonald, C.
Metabolic syndrome in patients attending psychiatric day centres: prevalence and associations. Psychiatrist
2012; 36: 326–31.
Lawrence, D, Hancock, K, Kisley, S.
The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ
2013; 346: f2539.
National Institute for Health and Care Excellence. Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease (Clinical Guideline CG67). NICE, 2008 (www.nice.org.uk/CG67).
National Institute for Health and Care Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Clinical Guideline CG1). NICE, 2002.
National Institute for Health and Care Excellence. Schizophrenia (Update) (CG82). NICE, 2009
Dalton, A, Soljak, M, Samarasundera, E, Millet, C, Majeed, A.
Prevalence of cardiovascular disease risk amongst the population eligible for the NHS health Check programme. Eur J Prev Cardiol
2013; 20: 142–50.
Health and Social Care Information Centre. Mental Health Bulletin: Annual Report from MHMDS returns – England 2011–12, initial national figures. HSCIC, 2013: 33–42.
Citrome, L, Yeomans, D.
Do guidelines for severe mental illness promote physical health and well-being?
2005; 19 (suppl 6): 102–9.
De Hert, M, Cohen, D, Bobes, J, Cetkovichbakamas, M, Leucht, S, Ndetei, D, et al Physical illness in patients with severe mental disorder. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry
2011; 10: 138–51.
NHS England. Commissioning for Quality and Innovation (CQUIN): 2014/15 Guidance. NHS England, 2013.
Smith, S, Yeomans, D, Bushe, C, Eriksson, C, Harrison, T, Holmes, R, et al A well-being programme in severe mental illness. Reducing risk for physical ill-health: a post-programme service evaluation at 2 years. Eur Psychiatry
2007; 22: 413–8.